EventsMOL2NET'21, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 7th ed.
Published
This submission belongs to the session 02. CHEMBIO.ORG-07: Org. Chem., Med. Chem., Mol. Biol., & Pharm. Industry Congress, Paris, France-Galveston, USA, 2021. of the event MOL2NET'21, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 7th ed.
Published date
18 Oct, 2021
Academic Editor
author-avatarHumbert G. Díaz
Citation
Beniamin Oskar Grabarek, Marcin Gralewski, Dorian Gładysz, Rafał Staszkiewicz, Alanine and aspartate aminotransferase and urea concentrations in patients with degenerative spine disease, in Proceedings of MOL2NET'21, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 7th ed., 25 January–30 December 2021, MDPI: Basel, Switzerland, doi: 10.3390/mol2net-07-11193
Share
Email
FaceBook
Twitter
Linkedin

Alanine and aspartate aminotransferase and urea concentrations in patients with degenerative spine disease

Marcin Gralewski 1
Dorian Gładysz 2,3
1. DepartDepartment of Histology, Cytophysiology and Embryology, Faculty of Medicine, University of Technology in Katowice, 41-800 Zabrze, Polandment of Histology, Cytophysiology and Embryology, Faculty of Medicine, University of Technology in Katowice, 41-8
2. Department of Histology, Cytophysiology and Embryology, Faculty of Medicine in Zabrze, University of Technology in Katowice, Poland
3. 5th Military Clinical Hospital with the SP ZOZ Polyclinic, Krakow, Poland
4. Department of Histology, Cytophysiology and Embryology, Faculty of Medicine in Zabrze, Academy of Silesia, 40-555 Katowice, Poland
5. Department of Neurosurgery, 5th Military Clinical Hospital with the SP ZOZ Polyclinic in Krakow, 30-901 Krakow, Poland
Abstract
Keywords
Alanine aminotransferase
aspartate aminotransferase
urea
degenerative spine disease